Neogen Corp
NASDAQ:NEOG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arion Entertainment Singapore Ltd
SGX:YYB
|
SG |
|
M
|
Manx Financial Group PLC
LSE:MFX
|
IM |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Neogen Corp
NASDAQ:NEOG
|
2.1B USD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9.9T JPY |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
30.1B CHF |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
38.7B USD |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
95.8B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.2B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
926.8B JPY |
Loading...
|
|
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
36.5B CNY |
Loading...
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.3B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Neogen Corp
Glance View
Founded in 1982, Neogen Corp. has steadily carved out its niche at the intersection of food safety and animal health, positioning itself as a vital player in agricultural diagnostics. The company's journey began in Lansing, Michigan, where it initially focused on innovative solutions to meet the growing demands of food safety and quality testing. By developing rapid tests for detecting foodborne bacteria and allergens, Neogen tapped into a critical market, addressing the increasing concerns about food safety amidst a complex global supply chain. This foundation in diagnostics set the stage for the growth Neogen would see over the ensuing decades. As Neogen expanded, it strategically diversified its offerings, moving beyond food safety into the broader realm of animal health. This expansion was not merely about developing products; it was about advancing the means by which farms and food producers monitor and ensure the health of their livestock and crops. The company's profits flow from the sale of its diagnostic products, which help minimize risks associated with food contamination and animal diseases. By providing a suite of solutions, from DNA testing for genetic traits and diseases in cattle to disinfectants and rodenticides that maintain farm hygiene, Neogen creates value for its clients by increasing their operational efficiency and safeguarding public health. This strategic blend of food safety and animal health products places Neogen at the heart of modern agricultural and food production systems, where safety and efficiency are paramount.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Neogen Corp is 45.2%, which is below its 3-year median of 48.6%.
Over the last 3 years, Neogen Corp’s Gross Margin has decreased from 48.3% to 45.2%. During this period, it reached a low of 45.2% on Feb 28, 2026 and a high of 51% on Feb 29, 2024.